Optional General Air/Land Contact Investigation Outcome Reporting Form

Optional General Air/Land Contact Investigation Outcome Reporting Form

1. Passenger Contact Information
Last name, First name	Assigned seat	Actual/Verified seat #	Sex		DOB (mm/dd/yy) OR	Age (yrs)	Country of birth	Country of residence
(Auto-populated)	(Auto-pop)							(Auto-pop, if available)
2. Contact investigation outcome for above named passenger contact
Were you able to contact this passenger?  Yes  No
If yes, date passenger was contacted: ____/____/_____, How did you reach the passenger? (please check all that apply)  Telephone  Sent letter or visited in person  E-mail  Emergency Contact  Other (please specify): _________________ (Continue)				If no, why could you not contact the passenger? (please check all that apply)  Incorrect locating info  No longer at temporary address  No response  Returned to country of residence  Other (please specify): _____________________________ (Stop here)
Additional comments:
3. Interview INFORMATION
Was contact interviewed?  No, why not?  Declined  Lives in different jurisdiction (specify) _______  Other (specify) ___________ (Stop here)  Yes (Continue) If contact is a woman of child-bearing age, is she pregnant?  No  Yes; what trimester at the time of flight?  1st  2nd  3rd
4. History of THIS disease or vaccine
History of disease:  No  Yes; Approximate date ___/___/___ or age (yrs) ____when had [this disease]  Unknown History of vaccination:  No  Yes; Number of doses of (disease auto-populated)-containing vaccine____,  Unknown Approximate dates or age received: 1. ___/___/___ or age ____; 2. ___/___/___ or age ____; 3. ___/___/___ or age ____; 4. ___/___/___ or age ____; 5. ___/___/___ or age ____    Unknown
5. intervention related to exposure on the flight
Did contact receive prophylaxis for this exposure?  No  Yes If no, please check why not:  Outside window for prophylaxis  Within window for prophylaxis but declined  Other (specify): _____________ If yes, please check what the contact received and the date (mm/dd) :  Antimicrobial drug; Date received: ___/___  Vaccination for this disease; Date received: ___/___  Immunoglobulin; Date received: ___/___
6. health since flight: first interview done less than ONE incubation period since flight
NOTE: If your first interview was after the incubation period (># days since the flight), please skip to section 7 Interview Date: ___/___/_____ Did contact report any signs or symptoms?  No (Stop here)  Yes; please check all that apply:  Fever ; Date of onset:­­­___/___/____ , Maximum temperature measured: ______oC/F  Feverishness (no temperature measured): __/__/____  Cough; Date of onset:­­­___/___/____  Rash; Date of onset:­­­___/___/____  Coryza; Date of onset:­­­___/___/____  Conjunctivitis; Date of onset:­­­___/___/____  Sore throat; Date of onset:­­­___/___/____  Swollen glands; Date of onset:­­­___/___/____  Vomiting; Date of onset:­­­___/___/____  Diarrhea; Date of onset:­­­___/___/____  Jaundice; Date of onset:­­­___/___/____  Headache; Date of onset:­­­___/___/____  Neck stiffness; Date of onset:­­­___/___/____  Unusual bleeding; Date of onset:­­­ ___/___/____  Decreased consciousness; Date of onset:­­­___/___/____  Difficulty breathing/shortness of breath; Date of onset:­­­____/___/____  Recent onset of focal weakness and/or paralysis; Date of onset:­­­___/___/____
7. health since flight: interview done at LEAST one incubation period since flight
Interview Date: ___/___/_____  N/A (did not follow-up with passenger after first interview) Did contact report any signs or symptoms?  No (Stop here)  Yes; please check all that apply:  Fever ; Date of onset:­­­___/___/____ , Maximum mesured temperature: ______oC/F  Feverishness (no temperature measured): __/__/____  Cough; Date of onset:­­­___/___/____  Rash; Date of onset:­­­___/___/____  Coryza; Date of onset:­­­___/___/____  Conjunctivitis; Date of onset:­­­___/___/____  Sore throat; Date of onset:­­­___/___/____  Swollen glands; Date of onset:­­­___/___/____  Vomiting; Date of onset:­­­___/___/____  Diarrhea; Date of onset:­­­___/___/____  Jaundice; Date of onset:­­­___/___/____  Headache; Date of onset:­­­___/___/____  Neck stiffness; Date of onset:­­­___/___/____  Unusual bleeding; Date of onset:­­­ ___/___/____  Decreased consciousness; Date of onset:­­­___/___/____  Difficulty breathing/shortness of breath; Date of onset:­­­____/___/____  Recent onset of focal weakness and/or paralysis; Date of onset:­­­___/___/____
8. DIAGNOSIS
If contact reported symptoms, was s/he evaluated by a health care provider?  No  Yes; Date(s): ___/___/____;___/___/___ If yes, was the contact diagnosed with [this disease]?  No  Yes; Date:­­­ ___/___/____  Insufficient Information How was diagnosis made?  IgM  Paired IgG  PCR  Culture  Epi-linked  Clinical diagnosis only  Other (specify):___________ Did the infection develop within the incubation period?  No  Yes Has anyone else developed [this disease] as a result of exposure to this person?  No  Yes; Who?__________ Was this passenger a close contact of the index case other than on the flight?  No  Yes, type:  Household  Travel companion  Social  Work  Other _____________________ Is this passenger a close contact with a known case of [this disease] other than the person on flight?  No  Yes; with whom? _______________ Date of last exposure (mm/dd): ____/____  Unknown Has contact visited other countries during the past month?  No  Unknown  Yes If yes, list the country with the corresponding dates (mm/dd): ________________ From: ____/____ to _____/_____ ________________ From: ____/____ to _____/_____ ________________ From: ____/____ to _____/_____
9. COMMENTS [free text field]

Public reporting burden of this collection of information is estimated to average 5 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB Control Number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer, 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; ATTN: PRA 0920-XXXX

Version: 10/29/10